Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2 V617F mutation

Haematologica. 2019 Jun;104(6):e236-e239. doi: 10.3324/haematol.2018.208082. Epub 2019 Jan 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles*
  • Amino Acid Substitution*
  • Biomarkers
  • Biomarkers, Tumor
  • Female
  • Genetic Testing
  • Humans
  • Janus Kinase 2 / genetics*
  • Leukemia, Myelomonocytic, Chronic / diagnosis
  • Leukemia, Myelomonocytic, Chronic / genetics*
  • Leukemia, Myelomonocytic, Chronic / mortality
  • Male
  • Mutation*
  • Neoplasm Staging
  • Prognosis
  • Survival Analysis

Substances

  • Biomarkers
  • Biomarkers, Tumor
  • Janus Kinase 2